Retinoblastoma – The Rare Eye Cancer

Retinoblastoma – The Rare Eye Cancer

Julie Scott, DNP
Julie Scott, DNP
Retinoblastoma | cancerGO

What is Retinoblastoma?

Retinoblastoma is a rare type of eye cancer that develops in the retina. The retina is the part of the eye that converts light into signals the brain uses to see. It is most commonly diagnosed in children under the age of 5, but can also occur in older people.

Risk factors

Risk factors for retinoblastoma include:

  • Having a family history
  • Inherited genetic mutations
  • Exposure to chemicals during pregnancy
  • Radiation exposure to their father


Symptoms of retinoblastoma can include:

  • A white pupil in photographs
  • Eye redness or pain
  • A crossed eye or lazy eye
  • Vision loss
  • Bulging of the eye
  • Bleeding in the eye


Any of the above symptoms noted in children should be reported to their healthcare provider quickly. This can lead to prompt evaluation with specialized eye exams and vision tests.

Other imaging studies may be used and can include ultrasound and MRI.

For most cancers, performing a biopsy to get a tissue to test for the presence of cancer cells is done. However, this can be a very risky procedure for retinoblastoma. Because of this, it is often diagnosed by eye exams and other imaging tests.


Treatment for retinoblastoma depends on the stage and location of cancer, the patient’s age, and overall health. Treatment options include eye-saving treatments such as:

  • Laser therapy
  • Cryotherapy (killing cancer cells by freezing them)
  • Radiation therapy
  • Chemotherapy

Other, more invasive treatment options can include surgical removal of the affected eye (enucleation) or removal of the entire eye and surrounding tissue (exenteration).

Retinoblastoma is a rare eye cancer that can affect children of all ages. Early diagnosis and treatment are essential for the best possible outcome. If you or your child have any symptoms of retinoblastoma, please see an ophthalmologist immediately.

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Preserving fertility before undergoing cancer treatment
March 1, 2023

Cancer treatment can significantly impact a person's fertility, of both sexes, particularly for young patients.  However, there are options available for those who wish to preserve their fertility before undergoing cancer treatment. Cancer treatments, such as chemotherapy, radiation therapy, and surgery, can damage the reproductive organs and potentially affect a…

Julie Scott, DNP


Who can benefit from cancerGO
January 18, 2023

CancerGO is a peer-to-peer support platform that provides resources, support, and information to cancer patients and their families. It is an initiative created to help cancer patients navigate the complexities of diagnosis, treatment, and recovery. But who can benefit from this platform? Below is a comprehensive look at how CancerGO…

cancerGO Founders


Why cancerGO and Why Now? -Bridging the Gap in Cancer Conversations
January 26, 2023

Cancer conversations are often fragmented due to the sheer amount of information that needs to be communicated. Diagnoses, treatments, medications, and progress can all be tricky topics for many people involved in the cancer care process. Add to this the complexity of dealing with multiple healthcare providers and family members…

cancerGO Founders


cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice